Lv412
739 积分 2021-07-11 加入
Growth Signaling Networks Orchestrate Cancer Metabolic Networks
20天前
已完结
Growth Signaling Networks Orchestrate Cancer Metabolic Networks
20天前
已关闭
Molecular basis for regulation of the class I phosphoinositide 3-kinases (PI3Ks), and their targeting in human disease
20天前
已完结
Epinephrine inhibits PI3Kα via the Hippo kinases
20天前
已关闭
Making PI3K superfamily enzymes run faster
20天前
已完结
Lessons from the Oncology Clinic: Repurposing PI3K Pathway Inhibitors for the Treatment of PTEN Hamartoma Tumor Syndrome
20天前
已完结
RAS at 40: Update from the RAS Initiative
2个月前
已完结
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
2个月前
已完结
Inavolisib: First Approval
2个月前
已完结
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Locally Advanced or Metastatic Breast Cancer
2个月前
已完结
皖公网安备34019202002308
